Interleukin-10 controls human peripheral PMN activation triggered by lipopolysaccharide

Cytokine

Volumn 62, Issue 3, 2013, Pages 426-432

  Martire Greco, Daiana ^a   Rodriguez Rodrigues, Nahuel ^a   Landoni, Verónica I ^a   Rearte, Barbara ^a   Isturiz, Martín A ^a   Fernández, Gabriela C ^a  

^a ACADEMIA NACIONAL DE MEDICINA   (Argentina)

Author keywords

IL 10; In vitro; LPS; Neutrophils; Sepsis

Indexed keywords

ALKALINE PHOSPHATASE; INTERLEUKIN 10; INTERLEUKIN 8; LIPOPOLYSACCHARIDE; TUMOR NECROSIS FACTOR ALPHA; IL10 PROTEIN, HUMAN; LIPOTEICHOIC ACID; REACTIVE OXYGEN METABOLITE; TEICHOIC ACID;

ARTICLE; CELL ACTIVATION; CELL FUNCTION; CELLULAR SECRETION; CONTROLLED STUDY; CYTOKINE RELEASE; ENZYME ACTIVITY; ERYTHROCYTE SEDIMENTATION RATE; FLOW CYTOMETRY; HUMAN; HUMAN CELL; NEUROMODULATION; NEUTROPHIL; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN DETERMINATION; PROTEIN FUNCTION; PROTEIN SECRETION; UPREGULATION; AUTOCRINE EFFECT; CELL SEPARATION; DEGRANULATION; DRUG EFFECTS; LEUKOCYTE ACTIVATION; METABOLISM; PHYSIOLOGY;

AUTOCRINE COMMUNICATION; CELL DEGRANULATION; CELL SEPARATION; HUMANS; INTERLEUKIN-10; INTERLEUKIN-8; LIPOPOLYSACCHARIDES; NEUTROPHIL ACTIVATION; NEUTROPHILS; REACTIVE OXYGEN SPECIES; TEICHOIC ACIDS;

EID: 84877802640     PISSN: 10434666     EISSN: 10960023     Source Type: Journal    
DOI: 10.1016/j.cyto.2013.03.025     Document Type: Article

References (35)

1. Cavaillon J.M., Adib-Conquy M., Fitting C., Adrie C., Payen D. Cytokine cascade in sepsis. Scand J Infect Dis 2003, 35:535-544.
2. Adrie C., Adib-Conquy M., Laurent I., Monchi M., Vinsonneau C., Fitting C., et al. Successful cardiopulmonary resuscitation after cardiac arrest as a "sepsis-like" syndrome. Circulation 2002, 106:562-568.
3. Kawamura T., Wakusawa R., Inada K. Interleukin-10 and interleukin-1 receptor antagonists increase during cardiac surgery. Can J Anaesth 1997, 44:38-42.
4. O'Nuallain E.M., Puri P., Mealy K., Reen D.J. Induction of interleukin-1 receptor antagonist (IL-1ra) following surgery is associated with major trauma. Clin Immunol Immunopathol 1995, 76:96-101.
5. Munford R.S., Pugin J. Normal responses to injury prevent systemic inflammation and can be immunosuppressive. Am J Respir Crit Care Med 2001, 163:316-321.
6. Cavaillon J.M., Annane D. Compartmentalization of the inflammatory response in sepsis and SIRS. J Endotoxin Res 2006, 12:151-170.
7. Howard M., Muchamuel T., Andrade S., Menon S. Interleukin 10 protects mice from lethal endotoxemia. J Exp Med 1993, 177:1205-1208.
8. Marchant A., Bruyns C., Vandenabeele P., Ducarme M., Gerard C., Delvaux A., et al. Interleukin-10 controls interferon-gamma and tumor necrosis factor production during experimental endotoxemia. Eur J Immunol 1994, 24:1167-1171.
9. Mosmann T.R. Properties and functions of interleukin-10. Adv Immunol 1994, 56:1-26.
10. Bussolati B., Mariano F., Montrucchio G., Piccoli G., Camussi G. Modulatory effect of interleukin-10 on the production of platelet-activating factor and superoxide anions by human leucocytes. Immunology 1997, 90:440-447.
11. Nikolaus S., Bauditz J., Gionchetti P., Witt C., Lochs H., Schreiber S. Increased secretion of pro-inflammatory cytokines by circulating polymorphonuclear neutrophils and regulation by interleukin 10 during intestinal inflammation. Gut 1998, 42:470-476.
12. Weiss S.J. Tissue destruction by neutrophils. N Engl J Med 1989, 320:365-376.
13. Detmers P.A., Lo S.K., Olsen-Egbert E., Walz A., Baggiolini M., Cohn Z.A. Neutrophil-activating protein 1/interleukin 8 stimulates the binding activity of the leukocyte adhesion receptor CD11b/CD18 on human neutrophils. J Exp Med 1990, 171:1155-1162.
14. Scapini P., Lapinet-Vera J.A., Gasperini S., Calzetti F., Bazzoni F., Cassatella M.A. The neutrophil as a cellular source of chemokines. Immunol Rev 2000, 177:195-203.
15. Xing Z., Jordana M., Kirpalani H., Driscoll K.E., Schall T.J., Gauldie J. Cytokine expression by neutrophils and macrophages in vivo: endotoxin induces tumor necrosis factor-alpha, macrophage inflammatory protein-2, interleukin-1 beta, and interleukin-6 but not RANTES or transforming growth factor-beta 1 mRNA expression in acute lung inflammation. Am J Respir Cell Mol Biol 1994, 10:148-153.
16. Boyum A. Separation of leukocytes from blood and bone marrow. introduction. Scand J Clin Lab Invest Suppl 1968, 97:7.
17. Coligan J.E. National Institutes of Health (US), Current protocols in immunology 1992, Greene Pub. Associates and Wiley-Interscience, New York.
18. Shiau M.Y., Chiou H.L., Lee Y.L., Kuo T.M., Chang Y.H. Establishment of a consistent L929 bioassay system for TNF-alpha quantitation to evaluate the effect of lipopolysaccharide, phytomitogens and cytodifferentiation agents on cytotoxicity of TNF-alpha secreted by adherent human mononuclear cells. Mediat Inflamm 2001, 10:199-208.
19. Bentala H., Verweij W.R., Huizinga-Van der Vlag A., van Loenen-Weemaes A.M., Meijer D.K., Poelstra K. Removal of phosphate from lipid A as a strategy to detoxify lipopolysaccharide. Shock 2002, 18:561-566.
20. Koyama I., Matsunaga T., Harada T., Hokari S., Komoda T. Alkaline phosphatases reduce toxicity of lipopolysaccharides in vivo and in vitro through dephosphorylation. Clin Biochem 2002, 35:455-461.
21. Lentsch A.B., Ward P.A. Regulation of inflammatory vascular damage. J Pathol 2000, 190:343-348.
22. Gay N.J., Gangloff M. Structure and function of toll receptors and their ligands. Annu Rev Biochem 2007, 76:141-165.
23. Nathan C. Neutrophils and immunity: challenges and opportunities. Nat Rev Immunol 2006, 6:173-182.
24. Cassatella M.A. The neutrophil: one of the cellular targets of interleukin-10. Int J Clin Lab Res 1998, 28:148-161.
25. Crepaldi L., Gasperini S., Lapinet J.A., Calzetti F., Pinardi C., Liu Y., et al. Up-regulation of IL-10R1 expression is required to render human neutrophils fully responsive to IL-10. J Immunol 2001, 167:2312-2322.
26. Kasama T., Strieter R.M., Lukacs N.W., Burdick M.D., Kunkel S.L. Regulation of neutrophil-derived chemokine expression by IL-10. J Immunol 1994, 152:3559-3569.
27. Laichalk L.L., Danforth J.M., Standiford T.J. Interleukin-10 inhibits neutrophil phagocytic and bactericidal activity. FEMS Immunol Med Microbiol 1996, 15:181-187.
28. Wright D.G. Human neutrophil degranulation. Methods Enzymol 1988, 162:538-551.
29. Sengelov H., Follin P., Kjeldsen L., Lollike K., Dahlgren C., Borregaard N. Mobilization of granules and secretory vesicles during in vivo exudation of human neutrophils. J Immunol 1995, 154:4157-4165.
30. Borregaard N., Christensen L., Bejerrum O.W., Birgens H.S., Clemmensen I. Identification of a highly mobilizable subset of human neutrophil intracellular vesicles that contains tetranectin and latent alkaline phosphatase. J Clin Invest 1990, 85:408-416.
31. Lew P.D., Monod A., Waldvogel F.A., Dewald B., Baggiolini M., Pozzan T. Quantitative analysis of the cytosolic free calcium dependency of exocytosis from three subcellular compartments in intact human neutrophils. J Cell Biol 1986, 102:2197-2204.
32. Borregaard N., Cowland J.B. Granules of the human neutrophilic polymorphonuclear leukocyte. Blood 1997, 89:3503-3521.
33. Shanley T.P., Vasi N., Denenberg A. Regulation of chemokine expression by IL-10 in lung inflammation. Cytokine 2000, 12:1054-1064.
34. Ismail H.F., Fick P., Zhang J., Lynch R.G., Berg D.J. Depletion of neutrophils in IL-10(-/-) mice delays clearance of gastric Helicobacter infection and decreases the Th1 immune response to Helicobacter. J Immunol 2003, 170:3782-3789.
35. Cavaillon J.M. "Septic Plasma": an immunosuppressive milieu. Am J Respir Crit Care Med 2002, 166:1417-1418.